Multiple Sclerosis Secondary Progressive clinical trials

Explore recruiting multiple sclerosis secondary progressive clinical trials.

Recruiting multiple sclerosis secondary progressive studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Multiple Sclerosis Secondary Progressive trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

CLASP MS: The study evaluating the efficacy and safety of Polish cladribine in the treatment of patients with secondary progressive multiple sclerosis - a phase 2, randomized, double-blind, placebo-controlled trial.

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Multiple Sclerosis Secondary Progressive trials by city

Multiple Sclerosis Secondary Progressive in Toronto Multiple Sclerosis Secondary Progressive in Vancouver Multiple Sclerosis Secondary Progressive in Montreal Multiple Sclerosis Secondary Progressive in Calgary Multiple Sclerosis Secondary Progressive in Edmonton Multiple Sclerosis Secondary Progressive in Ottawa Multiple Sclerosis Secondary Progressive in Winnipeg Multiple Sclerosis Secondary Progressive in Quebec City Multiple Sclerosis Secondary Progressive in Hamilton Multiple Sclerosis Secondary Progressive in Kitchener Multiple Sclerosis Secondary Progressive in London Multiple Sclerosis Secondary Progressive in Halifax Multiple Sclerosis Secondary Progressive in New York Multiple Sclerosis Secondary Progressive in Los Angeles Multiple Sclerosis Secondary Progressive in Chicago Multiple Sclerosis Secondary Progressive in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease